A commercial flock of broiler chickens on the Eastern Shore has tested positive for H5N1, or bird flu.
Coping with abrupt loss after natural disasters
The abrupt loss of a home due to a natural disaster such as wildfires and other events beyond one’s control can leave people feeling hopeless. A Baylor College of Medicine expert gives advice on ways to cope with these kinds of tragedies and shares some ways others can provide support to those impacted.
New online guide launched to support people affected by lichen sclerosus
A new online guide has been launched to support and empower people with vulval lichen sclerosus (LS) to learn about the condition, access the right treatment and live more comfortably. It is estimated that about 1 in 100 women have vulval LS. It can be diagnosed at any age, but it seems to happen most often after menopause. Nobody knows exactly what causes LS.
Wearable device uses bioimpedance to track joint swelling and damage
Samer Mabrouk started playing squash as an undergraduate at Georgia Tech. Ankle injuries were to be expected, and resting for a few days was all he needed to get back on the court. Now a research engineer in the School of Electrical and Computer Engineering, Mabrouk hasn’t put his racket down, but he gets injured more often—and rest isn’t enough anymore.
ACIP immunization schedules issued for children, adults
The Advisory Committee on Immunization Practices (ACIP)-approved immunization schedules for children and adolescents and for adults for 2025 have been published in the Jan. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
FDA approves Omvoh for moderately to severely active Crohn’s disease
The U.S. Food and Drug Administration has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn’s disease in adults.
Many health care providers with psychopathology are not seeking care, research reveals
More than one-quarter of U.S. health care providers reported meeting diagnostic criteria for psychopathology during the pandemic, but only 38 percent of these reported seeking care, according to research published in the Jan. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Genetically modified mice hint at tau hyperphosphorylation’s early role in neurodegenerative diseases
Tau is a microtubule-associated protein that helps to stabilize the structure of neurons, specifically by supporting microtubules, cylindrical structures that contribute to cell motility, intracellular transport and the maintenance of a cell’s shape over time. While tau has an important neurophysiological function, when it undergoes pathological changes and accumulates in the brain, this protein has been found to contribute to some neurodegenerative diseases, broadly defined as tauopathies.
Genetic reanalysis results in more than 500 patients receiving diagnosis
The European consortium for Solving the Unsolved Rare Diseases has demonstrated the significance of international collaboration to address the unmet medical needs for rare diseases’ diagnosis. More than 500 European patients with unknown conditions have received a diagnosis through new genetic research. This includes patients with rare neurological disorders, severe intellectual disabilities, muscle diseases, and hereditary gastrointestinal cancer.
Brain changes in Huntington’s disease decades before diagnosis may guide future prevention trials
Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately 20 years before a clinical motor diagnosis in people with Huntington’s disease, finds a study led by UCL researchers.